CRH (CRH) Financials

$91.57 -0.39 (-0.43%)

As of 11:07 AM Eastern

Annual Income Statements for CRH

This table shows CRH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	3,492	3,178	3,862	2,630	1,304	-	2,889	2,240	1,280	685
Consolidated Net Income / (Loss)	3,521	3,072	3,889	2,686	1,165	1,738	2,889	2,305	1,336	792
Net Income / (Loss) Continuing Operations	3,521	3,072	2,699	2,507	1,009	-	1,526	2,010	1,251	700
Total Pre-Tax Income	4,714	4,014	3,461	3,102	1,454	-	1,993	2,024	1,704	1,000
Total Operating Income	4,925	4,186	3,809	3,327	2,026	-	2,446	2,315	2,007	1,267
Total Gross Profit	12,701	11,963	10,815	9,827	8,565	9,273	9,058	8,863	8,651	7,240
Total Revenue	35,572	34,949	32,723	29,206	25,888	-	27,424	26,011	26,078	23,259
Operating Revenue	35,572	34,949	32,723	29,206	25,888	-	27,424	26,011	26,078	23,259
Total Cost of Revenue	22,871	22,986	21,908	19,379	17,323	-	18,391	17,148	17,427	16,019
Operating Cost of Revenue	22,871	22,986	21,908	19,379	17,323	-	18,391	17,148	17,427	16,019
Total Operating Expenses	7,776	7,777	7,006	6,500	6,539	-	6,612	6,548	6,643	5,973
Selling, General & Admin Expense	7,852	7,486	7,056	6,538	-	-	-	-	-	-
Impairment Charge	161	357	0.00	0.00	-	-	-	-	-	-
Other Special Charges / (Income)	-237	-66	-50	-38	-	-	-	-	-	-
Total Other Income / (Expense), net	-211	-172	-348	-225	-589	-	-453	-356	-359	-375
Interest Expense	612	376	344	315	438	-	-	362	411	431
Interest & Investment Income	143	206	65	0.00	0.00	-	-	14	8.42	8.69
Other Income / (Expense), net	258	-2.00	-69	90	-151	-	-453	-8.41	44	48
Income Tax Expense	1,085	925	762	650	445	-	467	14	453	300
Other Gains / (Losses), net	-108	-17	0.00	55	-	-	-	-	-	-
Net Income / (Loss) Discontinued Operations	0.00	0.00	1,190	179	312	-	1,388	296	85	92
Net Income / (Loss) Attributable to Noncontrolling Interest	29	-106	27	56	-	-	-	-	-	-
Basic Earnings per Share	$5.06	$4.36	$5.15	$3.35	$1.43	-	-	$2.72	$1.50	$0.89
Weighted Average Basic Shares Outstanding	683.30M	723.90M	758.30M	780.20M	795.14M	799.64M	843.39M	838.96M	-	-
Diluted Earnings per Share	$5.02	$4.33	$5.11	$3.32	$1.42	-	-	$2.71	$1.49	$0.89
Weighted Average Diluted Shares Outstanding	689.50M	729.20M	764.10M	786.80M	795.14M	799.64M	843.39M	838.96M	-	-
Weighted Average Basic & Diluted Shares Outstanding	676.48M	690.36M	752.14M	774.14M	795.14M	799.64M	843.39M	838.96M	-	-
Cash Dividends to Common per Share	$1.40	$1.33	$1.27	$1.21	-	-	-	-	-	-

This table shows CRH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Net Income / (Loss) Attributable to Common Shareholders	-94	703	1,376	1,297	116	701	1,306	1,199	-28
Consolidated Net Income / (Loss)	-98	709	1,389	1,309	114	573	1,318	1,212	-31
Net Income / (Loss) Continuing Operations	-98	709	1,389	1,309	114	573	1,318	1,212	-31
Total Pre-Tax Income	-146	987	1,895	1,733	99	755	1,720	1,578	-39
Total Operating Income	18	1,104	1,964	1,829	28	783	1,788	1,613	2.00
Total Gross Profit	1,837	3,160	4,059	3,675	1,807	2,951	3,763	3,630	1,619
Total Revenue	6,756	8,870	10,515	9,654	6,533	8,685	10,128	9,709	6,427
Operating Revenue	6,756	8,870	10,515	9,654	6,533	8,685	10,128	9,709	6,427
Total Cost of Revenue	4,919	5,710	6,456	5,979	4,726	5,734	6,365	6,079	4,808
Operating Cost of Revenue	4,919	5,710	6,456	5,979	4,726	5,734	6,365	6,079	4,808
Total Operating Expenses	1,819	2,056	2,095	1,846	1,779	2,168	1,975	2,017	1,617
Selling, General & Admin Expense	1,833	1,933	2,184	1,948	1,787	1,839	1,990	2,035	1,622
Other Special Charges / (Income)	-14	-38	-89	-102	-8.00	-28	-15	-18	-5.00
Total Other Income / (Expense), net	-164	-117	-69	-96	71	-28	-68	-35	-41
Interest Expense	181	160	164	155	133	91	131	73	81
Interest & Investment Income	37	31	33	36	43	68	62	36	40
Other Income / (Expense), net	-20	12	62	23	161	-5.00	1.00	2.00	0.00
Income Tax Expense	-58	143	531	430	-19	144	416	379	-14
Other Gains / (Losses), net	-10	-135	25	6.00	-4.00	-38	14	13	-6.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-4.00	6.00	13	12	-2.00	-128	12	13	-3.00
Basic Earnings per Share	($0.15)	$1.02	$1.99	$1.89	$0.16	$0.97	$1.81	$1.63	($0.05)
Weighted Average Basic Shares Outstanding	676.70M	683.30M	681.60M	685.50M	687.80M	723.90M	718.20M	734.70M	742.90M
Diluted Earnings per Share	($0.15)	$1.01	$1.97	$1.88	$0.16	$0.96	$1.80	$1.62	($0.05)
Weighted Average Diluted Shares Outstanding	676.70M	689.50M	685.50M	688.80M	693.40M	729.20M	722.10M	738.20M	742.90M
Weighted Average Basic & Diluted Shares Outstanding	676.00M	676.48M	679.34M	682.78M	686.68M	690.36M	-	-	-
Cash Dividends to Common per Share	$0.37	-	$0.35	$0.35	$0.35	-	$0.25	$0.00	$1.03

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-2,631	454	153	-1,938	3,466	1,552	-5,946	-5,388	-4,133	-4,181
Net Cash From Operating Activities	4,989	5,017	3,800	3,979	4,116	3,881	-3,885	-2,392	-1,510	1,057
Net Cash From Continuing Operating Activities	4,989	5,017	3,800	3,979	4,116	2,580	-3,885	-2,392	-1,510	1,057
Net Income / (Loss) Continuing Operations	3,521	3,072	3,889	2,686	1,165	2,181	0.00	0.00	0.00	0.00
Consolidated Net Income / (Loss)	3,521	3,072	3,889	2,686	1,165	2,181	-	-	-	-
Depreciation Expense	1,798	1,633	1,577	1,551	1,624	1,721	1,265	1,208	1,061	916
Non-Cash Adjustments To Reconcile Net Income	-14	547	-1,242	27	1,185	-1,024	-4,539	-3,285	-2,511	205
Changes in Operating Assets and Liabilities, net	-316	-235	-424	-285	142	-364	-611	-315	-60	-64
Net Cash From Investing Activities	-6,291	-2,391	-917	-2,513	-1,347	217	-5,400	-3,466	-1,054	-8,886
Net Cash From Continuing Investing Activities	-6,291	-2,397	-917	-2,513	-1,347	-2,040	-5,400	-3,466	-1,054	-8,886
Purchase of Property, Plant & Equipment	-2,578	-1,817	-1,523	-1,554	-996	-1,374	-1,324	-1,254	-	-
Acquisitions	-4,900	-640	-3,253	-1,494	-351	-727	-4,076	-2,211	-	-
Purchase of Investments	-9.00	-1.00	-11	0.00	-	-	-	-	-	-
Sale of Property, Plant & Equipment	272	104	115	387	-	-	-	-	-897	-958
Divestitures	1,001	0.00	3,712	120	-	-	-	-	-157	-7,927
Sale and/or Maturity of Investments	44	44	36	32	-	39	-	-	-	-
Other Investing Activities, net	-121	-87	7.00	-4.00	-	22	-	-	-	-
Net Cash From Financing Activities	-1,186	-2,380	-2,499	-3,107	697	2,546	3,339	470	-1,570	3,648
Net Cash From Continuing Financing Activities	-1,186	-2,378	-2,499	-3,107	697	-2,485	3,339	470	-1,570	3,648
Repayment of Debt	-1,859	-1,462	-364	-1,183	-4,943	-996	-291	-434	0.00	-41
Repurchase of Common Equity	-1,482	-3,067	-1,178	-896	-249	-954	-921	-3.60	-	-
Payment of Dividends	-1,740	-975	-943	-946	-722	-663	-633	-573	-379	-416
Issuance of Debt	4,001	3,163	38	0.00	6,611	106	5,184	1,480	-1,191	4,105
Other Financing Activities, net	-106	-37	-52	-82	-	22	-	-	-	-
Effect of Exchange Rate Changes	-143	208	-231	-297	-	-	-	-	-	-
Cash Interest Paid	599	418	329	340	432	-	394	381	364	328
Cash Income Taxes Paid	960	959	1,043	642	-	-	-	-	-	-

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Net Change in Cash & Equivalents	-407	679	-866	637	-3,081	668	1,447	-375	-1,286
Net Cash From Operating Activities	-659	2,730	1,486	1,485	-712	2,423	1,631	1,634	-671
Net Cash From Continuing Operating Activities	-659	2,730	1,486	1,485	-712	2,423	1,631	1,634	-671
Net Income / (Loss) Continuing Operations	-98	709	1,389	1,309	114	573	1,318	1,212	-31
Consolidated Net Income / (Loss)	-98	709	1,389	1,309	114	573	1,318	1,212	-31
Depreciation Expense	477	510	467	424	397	446	402	401	384
Non-Cash Adjustments To Reconcile Net Income	16	326	-155	-80	-105	451	16	44	36
Changes in Operating Assets and Liabilities, net	-1,054	1,185	-215	-168	-1,118	953	-105	-23	-1,060
Net Cash From Investing Activities	-964	-1,886	-1,788	-521	-2,096	-662	-759	-478	-492
Net Cash From Continuing Investing Activities	-964	-1,886	-1,788	-521	-2,096	-668	-759	-478	-492
Purchase of Property, Plant & Equipment	-645	-943	-505	-624	-506	-642	-404	-439	-332
Acquisitions	-585	-1,047	-1,331	-316	-2,206	-79	-363	-43	-155
Purchase of Investments	20	12	-18	10	-13	-4.00	-4.00	9.00	-2.00
Sale of Property, Plant & Equipment	35	-908	84	357	739	40	22	36	6.00
Divestitures	36	919	27	-	-	-5.00	5.00	-	-
Sale and/or Maturity of Investments	9.00	22	7.00	9.00	6.00	21	11	4.00	8.00
Other Investing Activities, net	166	59	-52	-12	-116	1.00	-26	-45	-17
Net Cash From Financing Activities	1,141	-42	-629	-339	-176	-1,283	649	-1,555	-191
Net Cash From Continuing Financing Activities	1,141	-42	-629	-339	-176	-1,281	649	-1,555	-191
Repayment of Debt	-1,533	-5.00	-163	-1,040	-651	-522	-91	-849	0.00
Repurchase of Common Equity	-310	-258	-317	-348	-559	-1,036	-1,072	-713	-246
Payment of Dividends	-17	-238	-249	-486	-767	-179	-12	-771	-13
Issuance of Debt	3,017	549	82	1,552	1,818	476	1,832	784	71
Other Financing Activities, net	-16	-90	18	-17	-17	-20	-8.00	-6.00	-3.00
Effect of Exchange Rate Changes	75	-123	65	12	-97	190	-74	24	68
Cash Interest Paid	63	227	156	171	45	174	43	147	54
Cash Income Taxes Paid	134	306	350	145	159	339	343	173	104

This table presents CRH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Total Assets	50,613	47,469	45,319	44,670	44,944	47,612	46,777	37,999	33,237
Total Current Assets	14,083	16,885	14,833	14,044	14,977	17,258	17,395	11,737	9,882
Cash & Equivalents	3,720	6,341	5,936	5,783	7,721	9,918	9,191	2,541	2,576
Restricted Cash	39	0.00	-	-	-	-	-	-	-
Accounts Receivable	4,820	4,507	4,300	4,569	4,086	4,231	4,665	4,361	4,186
Inventories, net	4,755	4,291	4,194	3,611	3,117	3,080	3,505	3,261	3,092
Other Current Assets	749	478	403	-	-	-	-	-	-
Other Current Nonoperating Assets	0.00	1,268	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	21,452	17,841	17,768	19,502	19,317	19,574	18,046	15,729	13,350
Total Noncurrent Assets	15,078	12,743	12,718	11,124	10,650	10,780	11,336	10,533	10,005
Long-Term Investments	737	620	649	653	626	775	1,332	1,499	1,367
Goodwill	11,061	9,158	9,199	-	-	-	-	-	-
Intangible Assets	1,211	1,041	1,088	9,848	9,373	9,475	9,656	8,666	8,165
Other Noncurrent Operating Assets	2,069	1,924	1,782	275	197	98	60	66	83
Total Liabilities & Shareholders' Equity	50,613	47,469	45,319	44,670	44,944	47,612	46,777	37,999	33,237
Total Liabilities	27,763	25,848	22,279	23,756	24,596	27,977	27,825	20,008	18,043
Total Current Liabilities	10,296	10,013	8,041	7,581	7,465	13,411	14,006	7,516	6,690
Short-Term Debt	2,999	1,866	1,491	549	1,257	6,616	7,213	380	289
Accounts Payable	3,207	3,149	2,930	6,409	5,503	5,461	5,817	5,718	5,550
Accrued Expenses	2,248	2,296	2,132	-	-	-	-	-	-
Other Current Liabilities	1,842	2,327	1,488	790	797	769	468	869	436
Other Current Nonoperating Liabilities	0.00	375	0.00	-	-	-	-	-	-
Total Noncurrent Liabilities	17,467	15,835	14,238	16,175	17,131	14,566	13,819	12,492	11,353
Long-Term Debt	10,969	9,776	8,145	9,938	10,958	9,211	9,959	9,202	7,906
Noncurrent Deferred & Payable Income Tax Liabilities	3,105	2,738	2,885	2,734	2,613	2,627	2,530	2,001	2,112
Other Noncurrent Operating Liabilities	3,393	3,321	3,208	937	954	855	844	836	713
Commitments & Contingencies	0.00	0.00	0.00	-	-	-	-	-	-
Redeemable Noncontrolling Interest	384	333	308	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	22,466	21,288	22,732	20,914	20,347	19,634	18,951	17,990	15,193
Total Preferred & Common Equity	21,607	20,854	22,157	20,233	40,004	19,027	18,349	17,406	14,616
Preferred Stock	1.00	1.00	1.00	-	7,493	-	-	-	-
Total Common Equity	21,606	20,853	22,156	20,232	12,162	19,027	18,349	17,406	14,616
Common Stock	712	750	745	309	333	335	352	344	299
Retained Earnings	24,036	22,918	22,495	19,770	11,565	11,350	11,705	9,493	6,809
Treasury Stock	-2,137	-2,199	-297	-195	-386	-360	-920	-18	-15
Accumulated Other Comprehensive Income / (Loss)	-1,005	-616	-787	-	-	-	-	-	-
Noncontrolling Interest	859	434	575	681	692	607	602	584	576

This table presents CRH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023
Total Assets	51,921	51,221	48,105	46,333	47,631	46,142	45,107
Total Current Assets	14,242	14,840	15,113	13,709	16,315	15,074	14,230
Cash & Equivalents	3,352	2,978	3,066	3,308	5,722	4,275	4,650
Restricted Cash	0.00	102	869	-	0.00	0.00	-
Accounts Receivable	5,141	6,422	5,893	4,798	5,972	6,119	4,706
Inventories, net	4,960	4,644	4,514	4,619	4,191	4,276	4,458
Other Current Assets	789	694	704	748	430	404	416
Other Current Nonoperating Assets	0.00	0.00	67	236	0.00	0.00	0.00
Plant, Property, & Equipment, net	22,179	21,289	19,235	18,878	18,103	18,155	17,997
Total Noncurrent Assets	15,500	15,092	13,757	13,746	13,213	12,913	12,880
Long-Term Investments	732	929	484	609	665	672	655
Goodwill	11,475	10,906	10,251	10,125	9,545	9,338	9,308
Intangible Assets	1,208	1,105	1,086	1,093	1,074	1,061	1,094
Other Noncurrent Operating Assets	2,085	2,152	1,936	1,919	1,929	1,842	1,823
Total Liabilities & Shareholders' Equity	51,921	51,221	48,105	46,333	47,631	46,142	45,107
Total Liabilities	29,564	28,055	26,654	25,591	24,983	23,433	22,963
Total Current Liabilities	8,712	10,668	10,548	9,997	9,191	9,671	9,255
Short-Term Debt	1,458	3,218	3,218	2,992	1,860	2,185	2,251
Accounts Payable	2,777	2,963	3,363	2,730	2,954	3,553	2,627
Accrued Expenses	2,270	2,513	2,272	2,241	2,457	2,335	2,079
Other Current Liabilities	2,207	1,974	1,681	1,990	1,920	1,598	2,298
Other Current Nonoperating Liabilities	0.00	0.00	14	44	0.00	0.00	0.00
Total Noncurrent Liabilities	20,852	17,387	16,106	15,594	15,792	13,762	13,708
Long-Term Debt	14,213	10,672	9,900	9,680	9,535	7,563	7,583
Noncurrent Deferred & Payable Income Tax Liabilities	3,141	3,168	2,914	2,684	3,050	3,010	2,972
Other Noncurrent Operating Liabilities	3,498	3,547	3,292	3,230	3,207	3,189	3,153
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	379	361	335	326	320	313	307
Total Equity & Noncontrolling Interests	21,978	22,805	21,116	20,416	22,328	22,396	21,837
Total Preferred & Common Equity	21,119	21,875	20,726	20,015	21,767	21,821	21,255
Preferred Stock	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Total Common Equity	21,118	21,874	20,725	20,014	21,766	21,820	21,254
Common Stock	587	683	651	631	725	693	722
Retained Earnings	23,375	23,831	23,030	22,346	23,936	22,892	21,692
Treasury Stock	-2,038	-2,141	-2,143	-2,166	-2,132	-1,140	-487
Accumulated Other Comprehensive Income / (Loss)	-806	-499	-813	-797	-763	-625	-673
Noncontrolling Interest	859	930	390	401	561	575	582

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.78%	6.80%	12.04%	12.82%	0.00%	0.00%	5.43%	-0.26%	12.12%	0.00%
EBITDA Growth	20.01%	9.40%	7.03%	41.98%	95.80%	-45.15%	-9.14%	12.91%	39.55%	0.00%
EBIT Growth	23.88%	11.87%	9.45%	82.24%	0.00%	-100.00%	-16.16%	12.43%	56.03%	0.00%
NOPAT Growth	17.70%	8.45%	12.95%	87.05%	0.00%	-100.00%	-18.51%	56.01%	66.12%	0.00%
Net Income Growth	14.62%	-21.01%	44.79%	130.56%	-32.97%	-39.84%	25.33%	72.54%	68.67%	0.00%
EPS Growth	15.94%	-15.26%	53.92%	133.80%	0.00%	0.00%	0.00%	81.60%	68.09%	0.00%
Operating Cash Flow Growth	-0.56%	32.03%	-4.50%	-3.33%	6.06%	199.90%	-62.44%	-58.43%	-242.79%	0.00%
Free Cash Flow Firm Growth	-179.97%	22.77%	70.22%	-7.67%	454.28%	63.29%	-257.21%	97.57%	0.00%	0.00%
Invested Capital Growth	27.21%	-2.61%	-0.79%	2.98%	-2.36%	2.23%	15.47%	14.08%	0.00%	0.00%
Revenue Q/Q Growth	0.52%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	6.11%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	6.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	8.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	4.02%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	1.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	6.56%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-2.19%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.71%	34.23%	33.05%	33.65%	33.08%	0.00%	33.03%	34.07%	33.17%	31.13%
EBITDA Margin	19.63%	16.64%	16.25%	17.01%	13.52%	0.00%	11.88%	13.51%	11.94%	9.59%
Operating Margin	13.85%	11.98%	11.64%	11.39%	7.83%	0.00%	8.92%	8.90%	7.70%	5.45%
EBIT Margin	14.57%	11.97%	11.43%	11.70%	7.24%	0.00%	7.27%	8.87%	7.87%	5.65%
Profit (Net Income) Margin	9.90%	8.79%	11.88%	9.20%	4.50%	0.00%	10.53%	8.86%	5.12%	3.41%
Tax Burden Percent	74.69%	76.53%	112.37%	86.59%	80.12%	0.00%	144.96%	113.89%	78.40%	79.24%
Interest Burden Percent	90.95%	95.94%	92.54%	90.78%	77.55%	0.00%	100.00%	87.76%	83.08%	76.03%
Effective Tax Rate	23.02%	23.04%	22.02%	20.95%	30.61%	0.00%	23.43%	0.71%	26.60%	30.00%
Return on Invested Capital (ROIC)	13.13%	12.51%	11.34%	10.15%	5.44%	0.00%	7.85%	11.06%	15.17%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	9.06%	8.14%	33.12%	11.21%	1.33%	0.00%	26.67%	11.22%	8.68%	0.00%
Return on Net Nonoperating Assets (RNNOA)	2.70%	1.25%	6.36%	2.87%	0.39%	0.00%	7.80%	2.84%	2.42%	0.00%
Return on Equity (ROE)	15.84%	13.76%	17.70%	13.02%	5.83%	9.01%	15.64%	13.89%	17.59%	0.00%
Cash Return on Invested Capital (CROIC)	-10.81%	15.16%	12.14%	7.21%	7.83%	-2.21%	-6.52%	-2.09%	-184.83%	0.00%
Operating Return on Assets (OROA)	10.57%	9.02%	8.31%	7.63%	4.05%	0.00%	4.70%	6.48%	6.17%	0.00%
Return on Assets (ROA)	7.18%	6.62%	8.64%	5.99%	2.52%	0.00%	6.82%	6.47%	4.02%	0.00%
Return on Common Equity (ROCE)	15.12%	13.25%	17.07%	10.22%	4.55%	8.73%	15.14%	13.41%	16.92%	0.00%
Return on Equity Simple (ROE_SIMPLE)	16.30%	14.73%	17.55%	13.28%	2.91%	9.13%	15.74%	13.24%	9.14%	0.00%
Net Operating Profit after Tax (NOPAT)	3,791	3,221	2,970	2,630	1,406	0.00	1,873	2,298	1,473	887
NOPAT Margin	10.66%	9.22%	9.08%	9.00%	5.43%	0.00%	6.83%	8.84%	5.65%	3.81%
Net Nonoperating Expense Percent (NNEP)	4.08%	4.37%	-21.78%	-1.06%	4.11%	-26.43%	-18.82%	-0.16%	6.49%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	10.41%	9.78%	9.18%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	64.30%	65.77%	66.95%	66.35%	66.92%	0.00%	67.06%	65.93%	66.83%	68.87%
SG&A Expenses to Revenue	22.07%	21.42%	21.56%	22.39%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.86%	22.25%	21.41%	22.26%	25.26%	0.00%	24.11%	25.17%	25.48%	25.68%
Earnings before Interest and Taxes (EBIT)	5,183	4,184	3,740	3,417	1,875	0.00	1,993	2,306	2,051	1,315
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6,981	5,817	5,317	4,968	3,499	1,787	3,258	3,515	3,113	2,231
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.91	2.46	1.30	2.03	2.68	1.65	1.09	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	6.73	4.81	2.43	3.96	11.67	3.29	2.29	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.77	1.46	0.88	1.41	1.26	0.00	0.73	0.00	0.00	0.00
Price to Earnings (P/E)	18.00	16.11	7.46	15.65	24.95	0.00	6.90	0.00	0.00	0.00
Dividend Yield	0.00%	1.95%	0.00%	2.26%	2.23%	2.15%	3.41%	2.27%	2.38%	2.84%
Earnings Yield	5.56%	6.21%	13.41%	6.39%	4.01%	0.00%	14.48%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.28	2.23	1.25	1.80	1.80	1.48	1.06	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.07	1.62	1.00	1.62	1.77	0.00	0.99	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	10.54	9.74	6.16	9.51	13.12	21.60	8.34	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	14.19	13.54	8.75	13.82	24.49	0.00	13.64	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	19.40	17.58	11.02	17.96	32.65	0.00	14.51	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.75	11.29	8.62	11.87	11.15	9.95	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	14.51	10.30	25.28	22.69	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.61	0.54	0.42	0.57	0.67	0.88	0.91	0.53	0.54	0.00
Long-Term Debt to Equity	0.48	0.45	0.35	0.54	0.60	0.54	0.53	0.51	0.52	0.00
Financial Leverage	0.30	0.15	0.19	0.26	0.29	0.34	0.29	0.25	0.28	0.00
Leverage Ratio	2.21	2.08	2.05	2.17	2.32	2.45	2.29	2.15	2.19	0.00
Compound Leverage Factor	2.01	1.99	1.89	1.97	1.80	0.00	2.29	1.88	1.82	0.00
Debt to Total Capital	37.94%	35.00%	29.49%	36.19%	39.98%	46.72%	47.54%	34.75%	35.04%	0.00%
Short-Term Debt to Total Capital	8.15%	5.61%	4.56%	1.68%	3.71%	17.95%	19.97%	1.38%	1.24%	0.00%
Long-Term Debt to Total Capital	29.79%	29.39%	24.93%	34.51%	36.27%	28.77%	27.57%	33.37%	33.80%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	22.10%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.38%	2.31%	2.70%	2.08%	2.04%	1.65%	1.67%	2.12%	2.46%	0.00%
Common Equity to Total Capital	58.68%	62.69%	67.81%	61.73%	35.88%	51.63%	50.80%	63.13%	62.50%	0.00%
Debt to EBITDA	2.00	2.00	1.81	2.39	3.87	9.64	5.27	2.73	2.63	0.00
Net Debt to EBITDA	1.36	0.80	0.57	1.08	1.48	3.65	2.04	1.56	1.36	0.00
Long-Term Debt to EBITDA	1.57	1.68	1.53	2.28	3.51	5.93	3.06	2.62	2.54	0.00
Debt to NOPAT	3.68	3.61	3.24	4.51	9.64	0.00	9.17	4.17	5.56	0.00
Net Debt to NOPAT	2.50	1.45	1.03	2.05	3.69	0.00	3.54	2.39	2.87	0.00
Long-Term Debt to NOPAT	2.89	3.03	2.74	4.30	8.75	0.00	5.32	4.00	5.37	0.00
Altman Z-Score	3.15	3.07	2.64	2.74	2.07	1.11	1.59	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	4.52%	3.70%	3.56%	21.49%	21.99%	3.13%	3.21%	3.50%	3.79%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.37	1.69	1.84	1.85	2.01	1.29	1.24	1.56	1.48	0.00
Quick Ratio	0.83	1.08	1.27	1.37	1.58	1.06	0.99	0.92	1.01	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3,122	3,903	3,179	1,868	2,023	-571	-1,555	-435	-17,949	0.00
Operating Cash Flow to CapEx	216.35%	292.88%	269.89%	340.96%	413.25%	282.46%	-293.43%	-190.71%	-168.23%	110.32%
Free Cash Flow to Firm to Interest Expense	-5.10	10.38	9.24	5.93	4.62	0.00	0.00	-1.20	-43.64	0.00
Operating Cash Flow to Interest Expense	8.15	13.34	11.05	12.63	9.40	0.00	0.00	-6.61	-3.67	2.45
Operating Cash Flow Less CapEx to Interest Expense	4.38	8.79	6.95	8.93	7.12	0.00	0.00	-10.08	-5.85	0.23
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.73	0.75	0.73	0.65	0.56	0.00	0.65	0.73	0.78	0.00
Accounts Receivable Turnover	7.63	7.94	7.38	6.75	6.23	0.00	6.08	6.09	6.23	0.00
Inventory Turnover	5.06	5.42	5.61	5.76	5.59	0.00	5.44	5.40	5.64	0.00
Fixed Asset Turnover	1.81	1.96	1.76	1.50	1.33	0.00	1.62	1.79	1.95	0.00
Accounts Payable Turnover	7.20	7.56	4.69	3.25	3.16	0.00	3.19	3.04	3.14	0.00
Days Sales Outstanding (DSO)	47.85	45.99	49.46	54.08	58.63	0.00	60.06	59.97	58.59	0.00
Days Inventory Outstanding (DIO)	72.18	67.37	65.02	63.36	65.29	0.00	67.15	67.62	64.76	0.00
Days Payable Outstanding (DPO)	50.72	48.26	77.80	112.18	115.51	0.00	114.46	119.93	116.25	0.00
Cash Conversion Cycle (CCC)	69.32	65.09	36.68	5.26	8.41	0.00	12.74	7.66	7.10	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	32,322	25,409	26,091	26,300	25,538	26,155	25,584	22,156	19,422	0.00
Invested Capital Turnover	1.23	1.36	1.25	1.13	1.00	0.00	1.15	1.25	2.69	0.00
Increase / (Decrease) in Invested Capital	6,913	-682	-209	762	-617	571	3,428	2,734	19,422	0.00
Enterprise Value (EV)	73,568	56,643	32,740	47,228	45,909	38,598	27,179	0.00	0.00	0.00
Market Capitalization	62,852	51,194	28,805	41,161	32,534	31,471	19,945	0.00	0.00	0.00
Book Value per Share	$31.80	$27.72	$29.22	$25.44	$15.21	$22.56	$21.87	$20.75	$0.00	$0.00
Tangible Book Value per Share	$13.74	$14.16	$15.65	$13.06	$3.49	$11.33	$10.36	$10.42	$0.00	$0.00
Total Capital	36,818	33,263	32,676	32,775	33,901	36,854	36,123	27,571	23,388	0.00
Total Debt	13,968	11,642	9,636	11,861	13,554	17,220	17,172	9,581	8,195	0.00
Total Long-Term Debt	10,969	9,776	8,145	11,312	12,297	10,604	9,959	9,202	7,906	0.00
Net Debt	9,472	4,681	3,051	5,386	5,190	6,520	6,632	5,501	4,228	0.00
Capital Expenditures (CapEx)	2,306	1,713	1,408	1,167	996	1,374	1,324	1,254	897	958
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3,027	2,397	2,347	1,190	1,031	538	1,394	2,019	882	0.00
Debt-free Net Working Capital (DFNWC)	6,786	8,738	8,283	7,012	8,769	10,463	10,602	4,601	3,482	0.00
Net Working Capital (NWC)	3,787	6,872	6,792	6,463	7,512	3,847	3,389	4,221	3,193	0.00
Net Nonoperating Expense (NNE)	270	149	-919	-56	241	-1,738	-1,016	-6.88	137	95
Net Nonoperating Obligations (NNO)	9,472	3,788	3,051	5,386	5,191	6,521	6,633	4,166	4,229	0.00
Total Depreciation and Amortization (D&A)	1,798	1,633	1,577	1,551	1,624	1,787	1,265	1,208	1,061	916
Debt-free, Cash-free Net Working Capital to Revenue	8.51%	6.86%	7.17%	4.07%	3.98%	0.00%	5.08%	7.76%	3.38%	0.00%
Debt-free Net Working Capital to Revenue	19.08%	25.00%	25.31%	24.01%	33.87%	0.00%	38.66%	17.69%	13.35%	0.00%
Net Working Capital to Revenue	10.65%	19.66%	20.76%	22.13%	29.02%	0.00%	12.36%	16.23%	12.24%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.06	$4.36	$5.07	$0.00	$142.90	$2.41	$3.02	$2.27	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	683.30M	723.90M	752.14M	0.00	795.14M	799.64M	843.39M	838.96M	0.00	0.00
Adjusted Diluted Earnings per Share	$5.02	$4.33	$5.03	$0.00	$141.80	$2.39	$3.01	$2.25	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	689.50M	729.20M	752.14M	0.00	795.14M	799.64M	843.39M	838.96M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	676.48M	690.36M	752.14M	0.00	795.14M	799.64M	843.39M	838.96M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	3,733	3,445	2,931	2,600	1,406	0.00	1,873	2,298	1,473	887
Normalized NOPAT Margin	10.49%	9.86%	8.96%	8.90%	5.43%	0.00%	6.83%	8.84%	5.65%	3.81%
Pre Tax Income Margin	13.25%	11.49%	10.58%	10.62%	5.62%	0.00%	7.27%	7.78%	6.54%	4.30%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.47	11.13	10.87	10.85	4.28	0.00	0.00	6.38	4.99	3.05
NOPAT to Interest Expense	6.20	8.57	8.63	8.35	3.21	0.00	0.00	6.36	3.58	2.06
EBIT Less CapEx to Interest Expense	4.70	6.57	6.78	7.14	2.01	0.00	0.00	2.91	2.81	0.83
NOPAT Less CapEx to Interest Expense	2.43	4.01	4.54	4.64	0.94	0.00	0.00	2.89	1.40	-0.17
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	49.42%	31.74%	24.25%	35.22%	61.97%	38.15%	21.91%	24.86%	28.35%	52.54%
Augmented Payout Ratio	91.51%	131.58%	54.54%	68.58%	83.35%	93.04%	53.79%	25.01%	28.35%	52.54%

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	3.41%	2.13%	3.82%	-0.57%	1.65%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	-18.94%	32.84%	13.78%	12.90%	51.81%	0.00%	0.00%	0.00%	0.00%
EBIT Growth	-101.06%	43.44%	13.25%	14.67%	9,350.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Growth	-62.25%	48.98%	4.29%	12.21%	2,283.84%	0.00%	0.00%	0.00%	0.00%
Net Income Growth	-185.96%	23.73%	5.39%	8.00%	467.74%	0.00%	0.00%	0.00%	0.00%
EPS Growth	-193.75%	5.21%	9.44%	16.05%	420.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	7.44%	12.67%	-8.89%	-9.12%	-6.11%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Growth	-78.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	15.83%	27.21%	19.49%	9.40%	9.87%	0.00%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	-23.83%	-15.64%	8.92%	47.77%	0.00%	-14.25%	4.32%	51.07%	0.00%
EBITDA Q/Q Growth	-70.79%	-34.78%	9.53%	288.40%	0.00%	-44.14%	8.68%	422.28%	0.00%
EBIT Q/Q Growth	-100.18%	-44.92%	9.40%	879.89%	0.00%	-56.51%	10.77%	80,650.00%	0.00%
NOPAT Q/Q Growth	-98.67%	-33.22%	2.80%	4,020.55%	0.00%	-53.25%	10.60%	87,442.41%	0.00%
Net Income Q/Q Growth	-113.82%	-48.96%	6.11%	1,048.25%	0.00%	-56.53%	8.75%	4,009.68%	0.00%
EPS Q/Q Growth	-114.85%	-48.73%	4.79%	1,075.00%	0.00%	-46.67%	11.11%	3,340.00%	0.00%
Operating Cash Flow Q/Q Growth	-124.14%	83.71%	0.07%	308.57%	0.00%	48.56%	-0.18%	343.52%	0.00%
Free Cash Flow Firm Q/Q Growth	22.49%	-50.07%	-228.21%	53.37%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	5.02%	-2.19%	9.80%	2.70%	0.00%	-8.12%	0.53%	3.14%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	27.19%	35.63%	38.60%	38.07%	27.66%	33.98%	37.15%	37.39%	25.19%
EBITDA Margin	7.03%	18.33%	23.71%	23.58%	8.97%	14.09%	21.63%	20.76%	6.01%
Operating Margin	0.27%	12.45%	18.68%	18.95%	0.43%	9.02%	17.65%	16.61%	0.03%
EBIT Margin	-0.03%	12.58%	19.27%	19.18%	2.89%	8.96%	17.66%	16.63%	0.03%
Profit (Net Income) Margin	-1.45%	7.99%	13.21%	13.56%	1.75%	6.60%	13.01%	12.48%	-0.48%
Tax Burden Percent	67.12%	71.83%	73.30%	75.53%	115.15%	75.89%	76.63%	76.81%	79.49%
Interest Burden Percent	7,300.00%	88.44%	93.53%	93.57%	52.38%	97.04%	96.14%	97.71%	-1,950.00%
Effective Tax Rate	0.00%	14.49%	28.02%	24.81%	-19.19%	19.07%	24.19%	24.02%	0.00%
Return on Invested Capital (ROIC)	0.21%	13.12%	15.67%	17.31%	0.64%	10.04%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.89%	9.57%	15.34%	16.32%	1.87%	8.43%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-0.41%	2.85%	4.99%	4.97%	0.57%	1.48%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-0.20%	15.97%	20.66%	22.28%	1.21%	11.51%	0.00%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	-2.76%	-10.81%	0.00%	0.00%	0.00%	15.36%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-0.02%	9.13%	13.79%	14.25%	2.22%	6.75%	0.00%	0.00%	0.00%
Return on Assets (ROA)	-1.06%	5.80%	9.46%	10.07%	1.34%	4.97%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	-0.19%	15.25%	19.68%	21.47%	1.17%	11.09%	0.00%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	15.67%	0.00%	15.47%	15.99%	16.07%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	13	944	1,414	1,375	33	634	1,356	1,226	1.40
NOPAT Margin	0.19%	10.64%	13.44%	14.24%	0.51%	7.30%	13.38%	12.62%	0.02%
Net Nonoperating Expense Percent (NNEP)	1.10%	3.55%	0.33%	0.98%	-1.23%	1.60%	0.75%	0.28%	0.72%
Return On Investment Capital (ROIC_SIMPLE)	0.03%	2.59%	-	-	-	1.92%	-	-	-
Cost of Revenue to Revenue	72.81%	64.37%	61.40%	61.93%	72.34%	66.02%	62.85%	62.61%	74.81%
SG&A Expenses to Revenue	27.13%	21.79%	20.77%	20.18%	27.35%	21.17%	19.65%	20.96%	25.24%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.92%	23.18%	19.92%	19.12%	27.23%	24.96%	19.50%	20.77%	25.16%
Earnings before Interest and Taxes (EBIT)	-2.00	1,116	2,026	1,852	189	778	1,789	1,615	2.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	475	1,626	2,493	2,276	586	1,224	2,191	2,016	386
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.82	2.91	2.89	2.48	2.98	2.46	1.83	1.83	1.70
Price to Tangible Book Value (P/TBV)	7.06	6.73	6.42	5.48	6.77	4.81	3.57	3.49	3.33
Price to Revenue (P/Rev)	1.66	1.77	1.79	1.47	1.70	1.46	0.00	0.00	0.00
Price to Earnings (P/E)	18.13	18.00	18.14	15.05	17.93	16.11	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	2.56%	2.71%	1.95%	1.95%	0.00%	0.00%	0.00%
Earnings Yield	5.52%	5.56%	5.51%	6.64%	5.58%	6.21%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.13	2.28	2.25	2.02	2.36	2.23	1.65	1.66	1.56
Enterprise Value to Revenue (EV/Rev)	2.02	2.07	2.11	1.74	1.97	1.62	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	10.53	10.54	11.32	9.70	11.47	9.74	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	14.49	14.19	15.38	13.22	15.79	13.54	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	19.21	19.40	21.35	17.76	21.06	17.58	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.35	14.75	15.91	12.62	13.87	11.29	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.70	0.61	0.60	0.61	0.61	0.54	0.50	0.43	0.44
Long-Term Debt to Equity	0.64	0.48	0.46	0.46	0.47	0.45	0.42	0.33	0.34
Financial Leverage	0.47	0.30	0.33	0.30	0.31	0.18	0.22	0.21	0.20
Leverage Ratio	2.28	2.21	2.16	2.13	2.13	2.08	2.10	2.03	2.04
Compound Leverage Factor	166.42	1.95	2.02	2.00	1.12	2.02	2.02	1.99	-39.72
Debt to Total Capital	41.21%	37.94%	37.48%	37.95%	37.92%	35.00%	33.47%	30.03%	30.75%
Short-Term Debt to Total Capital	3.83%	8.15%	8.68%	9.31%	8.95%	5.61%	5.46%	6.73%	7.04%
Long-Term Debt to Total Capital	37.38%	29.79%	28.80%	28.64%	28.97%	29.39%	28.01%	23.30%	23.71%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.26%	3.38%	3.48%	2.10%	2.18%	2.31%	2.59%	2.74%	2.78%
Common Equity to Total Capital	55.53%	58.68%	59.03%	59.95%	59.90%	62.69%	63.94%	67.23%	66.46%
Debt to EBITDA	2.28	2.00	2.11	2.09	2.11	2.00	0.00	0.00	0.00
Net Debt to EBITDA	1.69	1.36	1.50	1.39	1.46	0.80	0.00	0.00	0.00
Long-Term Debt to EBITDA	2.07	1.57	1.62	1.58	1.61	1.68	0.00	0.00	0.00
Debt to NOPAT	4.16	3.68	3.98	3.82	3.86	3.61	0.00	0.00	0.00
Net Debt to NOPAT	3.08	2.50	2.83	2.54	2.67	1.45	0.00	0.00	0.00
Long-Term Debt to NOPAT	3.78	2.89	3.06	2.89	2.95	3.03	0.00	0.00	0.00
Altman Z-Score	2.66	2.89	2.92	2.80	2.94	2.83	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	4.56%	4.52%	4.75%	3.66%	3.77%	3.70%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	1.63	1.37	1.39	1.43	1.37	1.69	1.78	1.56	1.54
Quick Ratio	0.97	0.83	0.88	0.85	0.81	1.08	1.27	1.07	1.01
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4,626	-5,969	-3,977	-1,212	-2,599	0.00	0.00	0.00	0.00
Operating Cash Flow to CapEx	-108.03%	147.49%	352.97%	556.18%	0.00%	402.49%	426.96%	405.46%	-205.83%
Free Cash Flow to Firm to Interest Expense	-25.56	-37.31	-24.25	-7.82	-19.54	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-3.64	17.06	9.06	9.58	-5.35	26.63	12.45	22.38	-8.28
Operating Cash Flow Less CapEx to Interest Expense	-7.01	5.49	6.49	7.86	-3.60	20.01	9.53	16.86	-12.31
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.73	0.73	0.72	0.74	0.77	0.75	0.00	0.00	0.00
Accounts Receivable Turnover	7.20	7.63	5.71	5.83	7.38	7.94	0.00	0.00	0.00
Inventory Turnover	4.82	5.06	5.18	5.19	5.05	5.42	0.00	0.00	0.00
Fixed Asset Turnover	1.74	1.81	1.80	1.87	1.90	1.96	0.00	0.00	0.00
Accounts Payable Turnover	8.38	7.20	7.74	6.59	8.55	7.56	0.00	0.00	0.00
Days Sales Outstanding (DSO)	50.67	47.85	63.92	62.63	49.48	45.99	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	75.80	72.18	70.43	70.35	72.33	67.37	0.00	0.00	0.00
Days Payable Outstanding (DPO)	43.58	50.72	47.17	55.35	42.68	48.26	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	82.89	69.32	87.18	77.63	79.12	65.09	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	33,944	32,322	33,047	30,097	29,305	25,409	27,656	27,510	26,673
Invested Capital Turnover	1.13	1.23	1.17	1.22	1.25	1.38	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	4,639	6,913	5,391	2,587	2,632	0.00	0.00	0.00	0.00
Enterprise Value (EV)	72,336	73,568	74,494	60,912	69,033	56,643	45,711	45,573	41,537
Market Capitalization	59,510	62,852	63,321	51,487	59,550	51,194	39,821	39,883	36,118
Book Value per Share	$31.22	$31.80	$32.04	$30.18	$29.10	$27.72	$28.94	$29.01	$28.26
Tangible Book Value per Share	$12.47	$13.74	$14.45	$13.67	$12.79	$14.16	$14.82	$15.18	$14.43
Total Capital	38,028	36,818	37,056	34,569	33,414	33,263	34,043	32,457	31,978
Total Debt	15,671	13,968	13,890	13,118	12,672	11,642	11,395	9,748	9,834
Total Long-Term Debt	14,213	10,969	10,672	9,900	9,680	9,776	9,535	7,563	7,583
Net Debt	11,587	9,472	9,881	8,699	8,755	4,681	5,008	4,801	4,529
Capital Expenditures (CapEx)	610	1,851	421	267	-233	602	382	403	326
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3,636	3,027	4,310	3,848	3,396	2,397	3,262	3,313	2,576
Debt-free Net Working Capital (DFNWC)	6,988	6,786	7,390	7,783	6,704	8,738	8,984	7,588	7,226
Net Working Capital (NWC)	5,530	3,787	4,172	4,565	3,712	6,872	7,124	5,403	4,975
Net Nonoperating Expense (NNE)	111	235	25	66	-81	61	38	14	32
Net Nonoperating Obligations (NNO)	11,587	9,472	9,881	8,646	8,563	3,788	5,008	4,801	4,529
Total Depreciation and Amortization (D&A)	477	510	467	424	397	446	402	401	384
Debt-free, Cash-free Net Working Capital to Revenue	10.16%	8.51%	12.18%	10.99%	9.69%	6.86%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	19.52%	19.08%	20.88%	22.24%	19.12%	25.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	15.45%	10.65%	11.79%	13.04%	10.59%	19.66%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.15)	$1.02	$1.99	$1.89	$0.16	$0.97	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	676.70M	683.30M	681.60M	685.50M	687.80M	723.90M	0.00	0.00	0.00
Adjusted Diluted Earnings per Share	($0.15)	$1.01	$1.97	$1.88	$0.16	$0.96	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	676.70M	689.50M	685.50M	688.80M	693.40M	729.20M	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	676.00M	676.48M	679.34M	682.78M	686.68M	690.36M	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	2.80	912	1,350	1,298	14	611	1,344	1,212	-2.10
Normalized NOPAT Margin	0.04%	10.28%	12.84%	13.45%	0.21%	7.04%	13.27%	12.48%	-0.03%
Pre Tax Income Margin	-2.16%	11.13%	18.02%	17.95%	1.52%	8.69%	16.98%	16.25%	-0.61%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.01	6.98	12.35	11.95	1.42	8.55	13.66	22.12	0.02
NOPAT to Interest Expense	0.07	5.90	8.62	8.87	0.25	6.96	10.35	16.79	0.02
EBIT Less CapEx to Interest Expense	-3.38	-4.59	9.79	10.23	3.17	1.93	10.74	16.60	-4.00
NOPAT Less CapEx to Interest Expense	-3.30	-5.67	6.05	7.15	2.00	0.35	7.43	11.27	-4.01
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	29.92%	49.42%	49.72%	43.63%	53.81%	31.74%	0.00%	0.00%	0.00%
Augmented Payout Ratio	67.18%	91.51%	116.48%	134.61%	158.87%	131.58%	0.00%	0.00%	0.00%

Frequently Asked Questions About CRH's Financials

When does CRH's fiscal year end?

According to the most recent income statement we have on file, CRH's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CRH's net income changed over the last 9 years?

CRH's net income appears to be on an upward trend, with a most recent value of $3.52 billion in 2024, rising from $792.09 million in 2015. The previous period was $3.07 billion in 2023. View CRH's forecast to see where analysts expect CRH to go next.

What is CRH's operating income?

CRH's total operating income in 2024 was $4.93 billion, based on the following breakdown:

Total Gross Profit: $12.70 billion
Total Operating Expenses: $7.78 billion

How has CRH revenue changed over the last 9 years?

Over the last 9 years, CRH's total revenue changed from $23.26 billion in 2015 to $35.57 billion in 2024, a change of 52.9%.

How much debt does CRH have?

CRH's total liabilities were at $27.76 billion at the end of 2024, a 7.4% increase from 2023, and a 53.9% increase since 2016.

How much cash does CRH have?

In the past 8 years, CRH's cash and equivalents has ranged from $2.54 billion in 2017 to $9.92 billion in 2019, and is currently $3.72 billion as of their latest financial filing in 2024.

How has CRH's book value per share changed over the last 9 years?

Over the last 9 years, CRH's book value per share changed from 0.00 in 2015 to 31.80 in 2024, a change of 3,180.5%.

Related Companies

This page (NYSE:CRH) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CRH (CRH) Financials

Frequently Asked Questions About CRH's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CRH (CRH) Financials

Annual Income Statements for CRH

Quarterly Income Statements for CRH

Annual Cash Flow Statements for CRH

Quarterly Cash Flow Statements for CRH

Annual Balance Sheets for CRH

Quarterly Balance Sheets for CRH

Annual Metrics And Ratios for CRH

Quarterly Metrics And Ratios for CRH

Frequently Asked Questions About CRH's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools